Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Surgery Today
Erschienen in: Surgery Today 4/2021

08.02.2021 | Original Article

Short-term changes and correlations of plasma spexin, kisspeptin, and galanin levels after laparoscopic sleeve gastrectomy

verfasst von: Mustafa Atabey, Muhammed Raşid Aykota, Mehmet İlker Özel, Gökhan Arslan

Erschienen in: Surgery Today | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the circulating levels of spexin, kisspeptin, galanin, and the correlations between these peptides after laparoscopic sleeve gastrectomy (LSG).

Methods

The plasma levels of the spexin, kisspeptin, and galanin and metabolic parameters (body mass index, weight loss, % excess weight loss, body fat, fasting glucose, HbA1C, and cholesterol levels) were measured (baseline, 1 month, and 3 months) and correlated in thirty adult individuals with obesity (22 female and 8 male) after LSG.

Results

The body mass index (BMI), body fat, fasting glucose, total and low-density lipoprotein cholesterol decreased, while high-density lipoprotein cholesterol and % EWL (excess weight loss) increased at 3 months after surgery. The plasma spexin levels increased at 3 months, kisspeptin levels increased at 1 month and stabilized afterward, and galanin levels decreased at 3 months after LSG. Significant correlations were found between metabolic parameters with spexin, kisspeptin, and galanin. In addition, spexin and kisspeptin were negatively correlated with galanin, while spexin was positively correlated with kisspeptin.

Conclusions

The biochemical data reveal evidence that LSG causes an increase in the levels of spexin, and kisspeptin and a decrease in galanin levels. Our findings, therefore, suggest a possible interaction between these novel peptides, which have potential roles in obesity and glucose metabolism.
Literatur
1.
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.PubMedPubMedCentralCrossRef
2.
Sherwood NE, Story M. Obesity: a public health perspective. Clin Fam Pract. 2002;4:469.CrossRef
3.
Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63:824–30.PubMedPubMedCentralCrossRef
4.
5.
6.
Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI, et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med. 2011;365:1969–79.PubMedPubMedCentralCrossRef
7.
Kehagias I, Zygomalas A, Karavias D, Karamanos S. Sleeve gastrectomy: have we finally found the holy grail of bariatric surgery? A review of the literature. Eur Rev Med Pharmacol Sci. 2016;20:4930–42.PubMed
8.
Kim DK, Yun S, Son GH, Hwang J, Park CR, Kim JI, et al. Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galanin receptor type II and III. Endocrinology. 2014;155:1864–73.PubMedCrossRef
9.
Walewski JL, Ge F, Lobdell H, Levin N, Schwartx GJ, Vasselli JR, et al. Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity. Obesity. 2014;22:1643–52.PubMedCrossRef
10.
Ge JF, Walewski JL, Anglade D, Berk PD. Regulation of hepatocellular fatty acid uptake in mouse models of fatty liver disease with and without functional leptin signaling: roles of NfKB and SREBP-1C and the effects of spexin. Semin Liver Dis. 2016;36:360–72.PubMedCrossRef
11.
Kumar S, Hossain MJ, Inge T, Balagopal PB. Roux-en-Y gastric bypass surgery in youth with severe obesity: 1-year longitudinal changes in spexin. Surg Obes Relat Dis. 2018;14:1537–43.PubMedCrossRef
12.
Andreozzi F, Mannino GC, Mancuso E, Spiga R, Perticone F, Sesti G. Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals. PLoS ONE. 2017;12(6):0179834.CrossRef
13.
Wolfe A, Hussain MA. The emerging role(s) for Kisspeptin in metabolism in mammals. Front Endocrinol (Lausanne). 2018;9:184.CrossRef
14.
Castellano JM, Navarro VM, Fernandez-Fernandez R, Roa J, Vigo E, Pineda R, et al. Expression of hypothalamic KiSS-1 system and rescue of defective gonadotropic responses by kisspeptin in streptozotocin-induced diabetic male rats. Diabetes. 2006;55:2602–10.PubMedCrossRef
15.
Flynn CR, Albaugh VL, Tamboli RA, Gregory JM, Bosompem A, Sidani RM, et al. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes. Am J Physiol Gastrointest Liver Physiol. 2020;318(2):G370–4.PubMedCrossRef
16.
Heberlein A, Muschler M, Frieling H, Lenz B, Wilhelm J, Gröschl M, et al. Decreased galanin serum levels are associated with alcohol-craving during withdrawal. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(2):568–72.PubMedCrossRef
17.
Poritsanos NJ, Mizuno TM, Lautatzis ME, Vrontakis M. Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. Int J Obes. 2009;33:1381–9.CrossRef
18.
Baranowska B, Wasilewska-Dziubinska E, Radzikowska M, Płonowski A, Roguski K, Neuropeptide Y. galanin, and leptin release in obese women and in women with anorexia nervosa. Metabolism. 1997;46:1384–9.PubMedCrossRef
19.
Brethauer SA, Kim J, el Chaar M, Papasavas P, Eisenberg D, Rogers A, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11:489–506.PubMedCrossRef
20.
Ibrahim DM, Mohamed NR, Fouad TA, Soliman AF. Short-term impact of laparoscopic sleeve gastrectomy on serum cartonectin and vaspin levels in obese subjects. Obes Surg. 2018;28:3237–45.PubMedCrossRef
21.
Ugi S, Yamamoto H, Kusunoki C, Kamo A, Ikeda K, Hashimoto T, et al. Laparoscopic sleeve gastrectomy leads to rapid improvement of glucose tolerance and insulin secretion with enhanced glucagon-like peptide (GLP-1) secretion. Diabetol Int. 2010;1:99–103.CrossRef
22.
Lopez-Nava G, Negi A, Bautista-Castaño I, Asokkumar R. Gut and metabolic hormones changes after endoscopic sleeve gastroplasty (ESG) vs. laparoscopic sleeve gastrectomy (LSG). Obes Surg. 2020;30:2642–51.PubMedCrossRef
23.
Mirabeau O, Perlas E, Severini C, Audero E, Gascuel O, Possenti R, et al. Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome Res. 2007;17(3):320–7.PubMedPubMedCentralCrossRef
24.
Ma A, Bai J, He M, Wong AOL. Spexin as a neuroendocrine signal with emerging functions. Gen Comp Endocrinol. 2018;265:90–6.PubMedCrossRef
25.
Walewski JL, Berk PD. Obesity-related genes and their proteins and uses thereof (Google Patents). 2013.
26.
Khadir A, Kavalakatt S, Madhu D, Devarajan S, Abubaker J, Al-Mulla F, et al. Spexin as an indicator of beneficial effects of exercise in human obesity and diabetes. Sci Rep. 2020;10:10635.PubMedPubMedCentralCrossRef
27.
Kumar S, Hossain J, Nader N, Aguirre R, Sriram S, Balagopal PB. Decreased circulating levels of spexin in obese children. J Clin Endocrinol Metab. 2016;101:2931–6.PubMedPubMedCentralCrossRef
28.
Al-DagKindly hri NM, Alenad A, Al-Hazmi H, Amer OE, Hussain SD, Alokail MS. Spexin levels are associated with metabolic syndrome components. Dis Markers. 2018;2018:1679690.
29.
Lin CY, Huang T, Zhao L, Zhong LLD, Lam WC, Fan BM, et al. Circulating Spexin levels negatively correlate with age, BMI, fasting glucose, and triglycerides in healthy adult women. J Endocr Soc. 2018;2:409–19.PubMedPubMedCentralCrossRef
30.
Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Poulet EL, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276:34631–6.PubMedCrossRef
31.
Ohtaki E, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001;411:613–7.PubMedCrossRef
32.
Cockwell H, Wilkinson DA, Bouzayen R, Imran SA, Brown R, Wilkinson M. KISS1 expression in human female adipose tissue. Arch Gynecol Obstet. 2013;287:143–7.PubMedCrossRef
33.
Kolodziejski PA, Pruszynska-Oszmalek E, Korek E, Sassek M, Szczepankiewicz D, Kaczmarek P, et al. Serum levels of spexin and kisspeptin negatively correlate with obesity and insulin resistance in women. Physiol Res. 2017;67(1):45–56.PubMed
34.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes 5-year outcomes. N Engl J Med. 2017;376:641–51.PubMedPubMedCentralCrossRef
35.
Rezk MY, Elkatawy HA. Kisspeptin and vaspin: Indicators of insulin sensitivity improvement before weight loss following sleeve gastrectomy in experimental type 2 diabetes mellitus. Int J Diabetes Res. 2017;6(4):91–8.
36.
Tatemoto K, Rökaeusn A, Jörnvall H, McDonald TJ, Mutt V. Galanin-a novel biologically active peptide from porcine intestine. FEBS Lett. 1983;164(1):124–8.PubMedCrossRef
37.
Fang P, Yu M, Shi M, Zhang Z, Sui Y, Guo L, et al. Galanin peptide family as a modulating target for contribution to metabolic syndrome. Gen Comp Endocrinol. 2012;179:115–20.PubMedCrossRef
38.
Li RY, Song HD, Shi WJ, Hu SM, Yang YS, Tang JF, et al. Galanin inhibits leptin expression and secretion in rat adipose tissue and 3T3-L1 adipocytes. J Mol Endocrinol. 2004;33:11–9.PubMedCrossRef
39.
Fang P, Yu M, Gu X, Shi M, Zhu Y, Zhang Z, et al. Low levels of plasma galanin in obese subjects with hypertension. J Endocrinol Invest. 2017;40:63–8.PubMedCrossRef
40.
Çetintürk T, Tülüceoğlu EE, Bülbül A, Calapoğlu NŞ, Öztürk Ö, Calapoğlu M. Influences of obesity on circulating galanin and C-reactive protein concentrations: results of a cross-sectional study. Future Vis J. 2018;2(2):1–6.
41.
Zhang Z, Fang P, Yu M, Wang Y, Li Y, Shi M, et al. Serum galanin concentration is increased in subjects with impaired glucose tolerance. Can J Diab. 2017;41(6):563–6.CrossRef
42.
Wong MK, Sze KH, Chen T, Cho CK, Law HCH, Chu IK, et al. Goldfish spexin: solution structure and novel function as a satiety factor in feeding control. Am J Physiol Endocrinol Metab. 2013;305:E348–66.PubMedCrossRef
43.
Shiba K, Kageyama H, Takenoya F, Shioda S. Galanin-like peptide and the regulation of feeding behavior and energy metabolism. FEBS J. 2010;277:5006–13.PubMedCrossRef
44.
Mazarati A, Lu X, Kilk K, Langel U, Wasterlain C, Bartfai T. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur J Neurosci. 2004;19:3235–44.PubMedCrossRef
45.
Lee DK, Nguyen T, O’Neill GP, Cheng R, Liu Y, Howard AD, et al. Discovery of a receptor related to the galanin receptors. FEBS Lett. 1999;446:103–7.PubMedCrossRef
46.
Cheung CC, Hohmann JG, Clifton DK, Steiner RA. Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus. Neuroscience. 2001;103:423–32.PubMedCrossRef
Metadaten
Titel
Short-term changes and correlations of plasma spexin, kisspeptin, and galanin levels after laparoscopic sleeve gastrectomy
verfasst von
Mustafa Atabey
Muhammed Raşid Aykota
Mehmet İlker Özel
Gökhan Arslan
Publikationsdatum
08.02.2021
Verlag
Springer Singapore
Erschienen in
Surgery Today / Ausgabe 4/2021
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-021-02240-6

Weitere Artikel der Ausgabe 4/2021

Surgery Today 4/2021 Zur Ausgabe

Original Article

Effectiveness of scheduled intravenous acetaminophen in the postoperative pain management of video-assisted thoracic surgery

Original Article

The treatment and survival of patients with postoperative recurrent thymic carcinoma and neuroendocrine carcinoma: a multicenter retrospective study

Review Article

Issues to be considered to address the future liver remnant prior to major hepatectomy

Original Article

FoundationOne® CDx gene profiling in Japanese pancreatic ductal adenocarcinoma patients: a single-institution experience

Original Article

Utility of the powered stapler for radical pulmonary resection: a propensity score-matched analysis

Review Article

Early versus late closure of temporary ileostomy after rectal cancer surgery: a meta-analysis

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.